Skip to main content

Table 4 Drugs which were used in the 1st line

From: Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy

Drugs Number
Interferon 15
Somatostatin-analogues 2
EP, EC 16
CAV 3
TC, TP, DP, DC 4
VIP 6
Adriamycin+streptozotocin 2
FOLFOX, XELOX 2
FP, FC 4
IP 1
5-FU+adriamycin+streptozocin 2
Dacarbazine 1
Sunitinib 5
RAD001 3
Total 66
  1. EP, etoposide and cisplatin; EC, etoposide carboplatin; CAV, cyclophosphamide, adriamycin and vincristine; TC, paclitaxel and carboplatin; TP, paclitaxel and cisplatin; DP, docetaxel and cisplatin; DC, docetaxel and carboplatin; VIP, etoposide, ifosfamide and cisplatin; FOLFOX, 5-fluorouracil (5-FU), leucovorin and oxaliplatin; XELOX, capecitabine, oxaliplatin; FP, 5-FU and cisplatin; FC, 5-FU and carboplatin; IP, irinotecan and cisplatin; RAD001, everolimus